PuraCath Medical Overview
- Founded
- 2010
- Status
- Private
- Latest Deal Type
- Series A
- Latest Deal Amount
- $471K
- Investors
- 13
PuraCath Medical General Information
Description
Developer of a dialysis disinfection device designed to reduce infectious complications associated with catheter connections. The company's device uses proprietary UV technology to keep patients healthy and protected from infection while minimizing dependence on user compliance, enabling healthcare providers to improve dialysis patients' quality of life by reducing infections.
Contact Information
Website
www.puracath.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Medical Supplies
Other Industries
Other Devices and Supplies
Primary Office
- 660 4th Street
- Suite 104
- San Francisco, CA 94107
- United States
+1 (650) 000-0000
PuraCath Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series A) | 23-Jun-2020 | $471K | 00.000 | 000.00 | Completed | Generating Revenue |
| 7. Accelerator/Incubator | 01-Jan-2017 | 00.000 | Completed | Generating Revenue | ||
| 6. Grant | 01-Jan-2017 | 00000 | 00.000 | Completed | Generating Revenue | |
| 5. Later Stage VC (Series A1) | 31-Jan-2016 | 000 | 00.000 | 0000 | Completed | Generating Revenue |
| 4. Grant | 02-Jun-2015 | 00.000 | 00000 | Completed | Generating Revenue | |
| 3. Early Stage VC (Series A) | 06-May-2013 | 00000 | 00000 | 00.000 | Completed | Startup |
| 2. Grant | 01-Jan-2012 | $650K | Completed | Generating Revenue | ||
| 1. Accelerator/Incubator | Completed | Startup |
PuraCath Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A1 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series A | 0,000,000 | 00.000000 | 00.00 | 00.0 | 00.0 | 00 | 00.0 | 00.000 |
PuraCath Medical Executive Team (8)
PuraCath Medical Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| Julia Rasooly | PuraCath Medical | Founder, Chief Executive Officer, President & Board Member | 000 0000 |
| Michael Rasooly | PuraCath Medical | Board Member | 000 0000 |
| Richard Ferrari | Self | Board Member & Business Advisor | 000 0000 |
PuraCath Medical Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Gregory Schears | Angel (individual) | Minority | 000 0000 | 000000 0 | |
| Richard Ferrari | Angel (individual) | Minority | 000 0000 | 000000 0 | |
| California Institute for Quantitative Biosciences | Accelerator/Incubator | 000 0000 | 000000 0 | ||
| National Institutes of Health | Government | 000 0000 | 000000 0 | ||
| U.S. Department of Health and Human Services | Government | 000 0000 | 000000 0 |